author-photo

Shuai Ge

Xi'an Jiaotong University

13

Papers

80

Citations

Citation Trend

Filter By

Papers (12) Sort By

Journal Conference Others

Testing of the inhibitory effects of loratadine and desloratadine on SARS-CoV-2 spike pseudotyped virus viropexis.

2021 Chemico-Biological Interactions
Show All
- Source
- Cite
- Save
Citations (10)
Astemizole as a drug to inhibit the effect of SARS-COV-2 in vitro.

2021 Microbial Pathogenesis
Show All
- Source
- Cite
- Save
Citations (2)
Azelastine inhibits viropexis of SARS-CoV-2 spike pseudovirus by binding to SARS-CoV-2 entry receptor ACE2.

2021 Virology
Show All
- Source
- Cite
- Save
Citations (1)
Resveratrol inhibits MRGPRX2-mediated mast cell activation via Nrf2 pathway.

2021 International Immunopharmacology
Show All
- Source
- Cite
- Save
Citations (5)
Screened antipsychotic drugs inhibit SARS-CoV-2 binding with ACE2 in vitro.

2021 Life Sciences
Show All
- Source
- Cite
- Save
Citations (10)
Repositioning of histamine H1 receptor antagonist: Doxepin inhibits viropexis of SARS-CoV-2 Spike pseudovirus by blocking ACE2.

2021 European Journal of Pharmacology
Show All
- Source
- Cite
- Save
Citations (15)
Design, synthesis, and evaluation of substance P analogue with potential anti-pseudoallergic activity

2021 New Journal of Chemistry
Show All
- Source
- Cite
- Save
Citations (0)
Roxithromycin inhibits compound 48/80-induced pseudo-allergy via the MrgprX2 pathway both in vitro and in vivo

2020 Cellular Immunology
Show All
- Source
- Cite
- Save
Citations (3)
MRGPRX2 is critical for clozapine induced pseudo-allergic reactions

2020 Immunopharmacology and Immunotoxicology
Show All
- Source
- Cite
- Save
Citations (2)
Chloroquine and hydroxychloroquine as ACE2 blockers to inhibit viropexis of COVID-19 Spike psedotype virus

2020 bioRxiv
Show All
- Source
- Cite
- Save
Citations (1)